Keyphrases
Pleckstrin
100%
Functional Node
100%
Myeloid Proliferation
100%
Myeloproliferative Neoplasms
80%
Janus Kinase 2 (JAK2)
26%
JAK Inhibitors
20%
JAK2V617F
20%
Knock-in Mouse Model
13%
Myeloproliferation
13%
PI3K-Akt Pathway
13%
Pten
13%
JAK2-STAT5
6%
PI3K Signaling
6%
Driver mutations
6%
Downstream Effectors
6%
Molecular Study
6%
Clinical Trials
6%
Thrombosis
6%
Successful Completion
6%
Cell Manufacturing
6%
In Vivo Evidence
6%
In(III)
6%
Biochemical Studies
6%
Acute Myeloid Leukemia
6%
Drug Resistance
6%
Myeloid Cells
6%
Normal Hematopoiesis
6%
Akt Activation
6%
In Silico
6%
Phosphoinositide 3-kinase (PI3K)
6%
Small Molecule Inhibitors
6%
Lethality
6%
Functional Mechanism
6%
Patient Samples
6%
Cell-based
6%
Mouse Model
6%
Bone Marrow Failure
6%
High-throughput Screening
6%
Vascular Occlusion
6%
Medicine and Dentistry
Pleckstrin
100%
Myeloproliferative Neoplasm
73%
Janus Kinase
33%
Janus Kinase Inhibitor
20%
Myeloproliferative Disorder
13%
Acute Myeloid Leukemia
6%
In Silico
6%
Thrombosis
6%
Akt Signaling
6%
Myeloid Cell
6%
In Vitro
6%
Vascular Occlusion
6%
Lethality
6%
High Throughput Screening
6%
Bone Marrow Disease
6%
Side Effect
6%
Clinical Trial
6%
Hematopoiesis
6%
Drug Resistance
6%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Pleckstrin
100%
Janus Kinase
33%
Janus Kinase Inhibitor
20%
Mouse Model
13%
Knockout Mouse
13%
Small Molecule
6%
Hematopoiesis
6%
High Throughput Screening
6%
Clinical Trial
6%
Akt Signaling
6%
STAT5
6%
Drug Resistance
6%